Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Sathyapalan

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Minerva Endocrinologica|April 27, 2011
Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?T Sathyapalan, S L Atkin
BMJ (Clinical Research Ed.)|April 30, 2009
Investigating hirsutismT Sathyapalan, Stephen L Atkin
European Journal of Endocrinology|November 19, 2011
Recent advances in cardiovascular aspects of polycystic ovary syndromeT Sathyapalan, S L Atkin
Climacteric : the Journal of the International Menopause Society|July 29, 2009
Effect of long-term, high-dose estrogen treatment on prolactin levels: a retrospective analysisT Sathyapalan, S González, S L Atkin
Seminars in Fetal & Neonatal Medicine|October 31, 2009
Obesity and gestational diabetesT Sathyapalan, D Mellor, S L Atkin
BMJ (Clinical Research Ed.)|June 18, 2011
Postural hypotensionT Sathyapalan, M M Aye, S L Atkin
Annals of Clinical Biochemistry|April 11, 2014
LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimationT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetes, Obesity & Metabolism|June 4, 2010
Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?T Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetes, Obesity & Metabolism|January 30, 2013
The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover studyT Sathyapalan, J Shepherd, S L Atkin, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Minerva Endocrinologica|April 27, 2011
Is there a role for immune and anti-in-flammatory therapy in type 2 diabetes?T Sathyapalan, S L Atkin
BMJ (Clinical Research Ed.)|April 30, 2009
Investigating hirsutismT Sathyapalan, Stephen L Atkin
European Journal of Endocrinology|November 19, 2011
Recent advances in cardiovascular aspects of polycystic ovary syndromeT Sathyapalan, S L Atkin
Climacteric : the Journal of the International Menopause Society|July 29, 2009
Effect of long-term, high-dose estrogen treatment on prolactin levels: a retrospective analysisT Sathyapalan, S González, S L Atkin
Seminars in Fetal & Neonatal Medicine|October 31, 2009
Obesity and gestational diabetesT Sathyapalan, D Mellor, S L Atkin
BMJ (Clinical Research Ed.)|June 18, 2011
Postural hypotensionT Sathyapalan, M M Aye, S L Atkin
Annals of Clinical Biochemistry|April 11, 2014
LDL cholesterol variability in patients with Type 2 diabetes taking atorvastatin and simvastatin: a comparison of two formulae for LDL-C estimationT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetes, Obesity & Metabolism|June 4, 2010
Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement?T Sathyapalan, S L Atkin, E S Kilpatrick
Diabetic Medicine : a Journal of the British Diabetic Association|October 31, 2008
Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target settingT Sathyapalan, S L Atkin, E S Kilpatrick
Diabetes, Obesity & Metabolism|January 30, 2013
The effect of atorvastatin and simvastatin on vitamin D, oxidative stress and inflammatory marker concentrations in patients with type 2 diabetes: a crossover studyT Sathyapalan, J Shepherd, S L Atkin, et al.
Pageof 5